Influence of Spironolactone Treatment on Endothelial Function in Non-Obese Women with Polycystic Ovary Syndrome

    Katica Bajuk Studen, Miran Šebeštjen, Marija Pfeifer, Janez Preželj
    New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that spironolactone treatment can normalize endothelial function and improve cholesterol levels in non-obese patients with polycystic ovary syndrome.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results